For procurement, supply chain & CFOs
Built for the buying committee, not the patient.
Tools, contract data, and reimbursement references for the people who own the AWC formulary and the wound care spend line. No clinical fluff — total cost of care, waste reduction, and coverage you can actually bill.
Aggregator
Formulary Consolidation
Buy every wound graft brand — MIMEDX, Organogenesis, Integra, Smith+Nephew, MTF — on one PO. 60–80% SKU reduction at parity coverage.
OpenUrgent
Emergency & Off-Contract Fill
Manufacturer backorder, GPO gap, or patient-specific brand? Same-day quotes, next-morning cold-chain delivery on amniotic and dHACM grafts.
OpenDecision tool
Total Cost of Ownership Calculator
Input usage, list price, application frequency, and healing rate. See true cost per healed patient — including waste.
OpenContracts
GPO Contract Access
Vizient, Premier, HealthTrust, Intalere. Contract identifiers and how to access pricing through your group purchasing org.
OpenReimbursement
HCPCS Q-Code Hub
Q4101–Q4205 reimbursement context, product matches, and 2026 ASP-based payment notes for Medicare-aligned billing.
OpenCoverage
Reimbursement Playbook
MAC jurisdictions, medical necessity documentation, and the 5-step coverage verification workflow.
OpenOutcomes
Procurement Case Studies
Real spend reduction, waste elimination, and formulary consolidation outcomes from SNFs, IDNs, and outpatient centers.
OpenComparison guides
Head-to-head procurement breakdowns — written for spend committees, not clinicians.
Cryopreserved vs. Lyophilized Amniotic Membrane Grafts: A Procurement Guide
Procurement directors selecting between cryopreserved and lyophilized (dehydrated) amniotic membrane allografts trade off storage infrastructure, waste rates, clinical handling, and per-application cost. This guide compares both formats on the factors that drive total cost of ownership, not just unit price.
dHACM vs. Synthetic Skin Substitutes: Procurement Decision Framework
dHACM allografts and synthetic skin substitutes occupy overlapping but distinct positions on most wound care formularies. This guide frames the procurement decision in terms of reimbursement pathway, evidence base, and supply chain risk — not just clinical preference.
Dual-Layer vs. Single-Layer Amniotic Grafts: Cost & Application Frequency
Dual-layer constructs combine amnion and chorion to deliver higher growth factor concentration. Single-layer amnion is lower-cost per unit but typically requires more applications per episode. This guide compares episode cost rather than unit cost.
Recent procurement case studies
Regional SNF Network Cuts AWC Spend 22% via Formulary Consolidation
14-facility regional skilled nursing network, ~600 chronic wound census
Hospital Outpatient Wound Center Reduces Reapplication Cost via Q4205 Conversion
Hospital outpatient wound center, ~1,800 annual visits, mixed DFU/VLU census
IDN Eliminates $340K Annual Cold Chain Waste by Switching Formats
6-hospital IDN with 11 affiliated outpatient and SNF sites
Advanced wound care procurement vocabulary
A working glossary of the supply chain, reimbursement, and clinical terms our procurement, formulary, and value-analysis customers use day-to-day when evaluating wound graft vendors.
- Supply chain logistics
- End-to-end coordination of graft sourcing, cold-chain storage, distribution to wound centers, and reverse logistics for expired or wasted units.
- Formulary management
- Pharmacy & Therapeutics or Value Analysis Committee process that adds, restricts, or removes a skin substitute from the approved on-formulary list.
- Value-based purchasing
- Contracting model that ties graft cost to outcomes — healing rate, reapplication count, or cost-per-healed-episode — instead of unit price alone.
- Capitation rates
- Per-member-per-month payment models where the provider absorbs graft cost; drives demand for lower-cost amniotic alternatives.
- DRG assignment
- MS-DRG that determines bundled payment for an inpatient wound-related admission; skin substitute cost is generally packaged into the DRG, not separately billed.
- APC payment
- OPPS Ambulatory Payment Classification used in HOPD (POS 22); low-cost and high-cost skin substitutes pack into one of two APC groups with the application CPT.
- Cold chain storage
- Temperature-controlled handling required for cryopreserved amniotic and cellular products from manufacturer through point of application.
- Graft waste reduction
- Right-sizing unit selection and JW-modifier discipline to minimize discarded sq cm and protect ASP+6% margin.
- Vendor consolidation
- IDN / GPO strategy to reduce the number of skin substitute SKUs and contracted suppliers — typically 60–80% SKU reduction at parity coverage.
- LCD coverage
- Local Coverage Determination published by each MAC defining covered indications, frequency limits, and approved product lists for skin substitute grafts.
- Prior authorization
- Payer requirement to document failed conservative care, wound measurements, and medical necessity before a skin substitute application is reimbursable.
- Episode of care
- Time-bounded clinical and economic unit used for TCO modeling — typically 12 weeks of weekly applications for a DFU or VLU.